Gail Boudreaux Elevance Health, Inc. (ELV) insider trading activity

Gail Boudreaux is President and CEO of Elevance Health, Inc.. Currently has a direct ownership of 126,709 shares of ELV, which is worth approximately $68.7 Million. The most recent transaction as insider was on Jul 22, 2024, when has been sold 34,000 shares (Common Stock) at a price of $501.74 per share, resulting in proceeds of $17,059,160. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 127K

7.58% 3M change

6.74% 12M change

Total Value Held $68.7 Million

GAIL BOUDREAUX Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 22 2024	SELL Open market or private sale	$17,059,160 $501.74 p/Share	34,000 Reduced 21.16%	126,709 Common Stock
Mar 01 2024	SELL Payment of exercise price or tax liability	$9,610,862 $499.11 p/Share	19,256 Reduced 14.05%	117,777 Common Stock
Mar 01 2024	BUY Grant, award, or other acquisition	-	42,932 Added 21.08%	160,709 Common Stock
Mar 02 2023	SELL Payment of exercise price or tax liability	$8,257,090 $468.78 p/Share	17,614 Reduced 11.48%	135,863 Common Stock
Mar 01 2023	SELL Payment of exercise price or tax liability	$1,158,973 $469.03 p/Share	2,471 Reduced 2.21%	109,180 Common Stock
Mar 01 2023	BUY Grant, award, or other acquisition	-	44,297 Added 22.4%	153,477 Common Stock
Nov 04 2022	SELL Bona fide gift	-	10,000 Reduced 8.24%	111,415 Common Stock
Mar 02 2022	SELL Payment of exercise price or tax liability	$762,441 $463.49 p/Share	1,645 Reduced 1.35%	120,639 Common Stock
Mar 01 2022	SELL Payment of exercise price or tax liability	$6,931,428 $451.5 p/Share	15,352 Reduced 15.18%	85,786 Common Stock
Mar 01 2022	BUY Grant, award, or other acquisition	-	36,498 Added 22.99%	122,284 Common Stock
Mar 02 2021	SELL Payment of exercise price or tax liability	$512,369 $311.66 p/Share	1,644 Reduced 1.61%	100,300 Common Stock
Mar 01 2021	SELL Payment of exercise price or tax liability	$11,077,475 $311.48 p/Share	35,564 Reduced 66.26%	18,109 Common Stock
Mar 01 2021	BUY Grant, award, or other acquisition	-	83,835 Added 45.13%	101,944 Common Stock
Dec 01 2020	SELL Payment of exercise price or tax liability	$4,634,420 $313.9 p/Share	14,764 Reduced 21.6%	53,594 Common Stock

Also insider at

ZBH

ZIMMER BIOMET HOLDINGS, INC. Healthcare

Director

TGT

TARGET CORP Consumer Defensive

Director

Gail Boudreaux

President and CEO

Minneapolis, MN

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ELV shares.

Notify only if

Value

Insider Trading

Get notified when an Elevance Health, Inc. insider buys or sells ELV shares.

Notify only if

Operation

Value

Type

News

Receive news related to Elevance Health, Inc.

Track Activities on ELV

Account